Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population-based cohort study

Hsu, Yao-ChunYao-ChunHsuLin, Yi-HsianYi-HsianLinLee, Teng-YuTeng-YuLeeNguyen, Mindie HMindie HNguyenTseng, Cheng-HaoCheng-HaoTsengHo, Hsiu JHsiu JHoKao, Feng-YuFeng-YuKaoJAW-TOWN LINWu, Chen-YiChen-YiWuWu, Chun-YingChun-YingWu2023-10-252023-10-252023-0802692813https://pubmed.ncbi.nlm.nih.gov/37341016/https://scholars.lib.ntu.edu.tw/handle/123456789/636504Finite nucleos(t)ide analogue (NUC) therapy has been proposed as an alternative treatment strategy for chronic hepatitis B (CHB).en[SDGs]SDG3Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population-based cohort studyjournal article10.1111/apt.17614373410162-s2.0-85163196099https://api.elsevier.com/content/abstract/scopus_id/85163196099